Safety and Efficacy of Bevacizumab in Cancer Patients with Inflammatory Bowel Disease
Background: The safety of bevacizumab in combination with chemotherapy in patients with inflammatory bowel disease (IBD) and digestive and nondigestive cancers is poorly documented. Methods: We retrospectively evaluated patient records of all adult cancer patients with IBD at our institution from Ap...
Main Authors: | Ruth Gabriela Herrera-Gómez, Miruna Grecea, Claire Gallois, Valérie Boige, Patricia Pautier, Barbara Pistilli, David Planchard, David Malka, Michel Ducreux, Olivier Mir |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/12/2914 |
Similar Items
-
Gene Identification in Inflammatory Bowel Disease via a Machine Learning Approach
by: Gerardo Alfonso Perez, et al.
Published: (2023-06-01) -
A Regional Survey of Awareness of Inflammatory Bowel Disease among the Saudi Population
by: Yaser Khalid Meeralam, et al.
Published: (2023-02-01) -
A Retrospective Analysis of Clinical Features and Treatment of the Inflammatory Bowel Disease in China
by: Shao S, et al.
Published: (2022-06-01) -
Inflammatory Bowel Disease in Young Adult
by: Dian Daniella, et al.
Published: (2020-07-01) -
News and controversy in inflammatory bowel disease treatment
by: Giulia Straforini, et al.
Published: (2013-04-01)